Alerts will be sent to your verified email
Verify Email
KRONOX
|
Kronox Lab Sciences
|
Titan Bio-Tech
|
Naperol Investments
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
33.43 % | 25.7 % | 5.47 % |
|
5yr Avg Net Profit Margin
|
19.7 % | 16.03 % | 18.23 % |
|
Price to Book
|
6.74 | 4.04 | 0.46 |
|
P/E
|
23.72 | 28.14 | 49.39 |
|
5yr Avg Cash Conversion Cycle
|
47.83 Days | 113.51 Days | 13.07 Days |
|
5yr Average Interest Coverage Ratio
|
63.83 | 26.4 | 126.22 |
|
5yr Avg ROCE
|
44.19 % | 31.72 % | 7.9 % |
|
5yr Avg Operating Profit Margin
|
26.99 % | 23.23 % | 29.16 % |
|
5 yr average Debt to Equity
|
0.0 | 0.2 | 0.1 |
|
5yr CAGR Net Profit
|
21.22 % | 28.58 % | -43.68 % |
|
5yr Average Return on Assets
|
27.09 % | 17.56 % | 4.72 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
74.21 % | 55.88 % | 70.76 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Kronox Lab Sciences
|
Titan Bio-Tech
|
Naperol Investments
|
|---|